Masong, Baby Girl .

HRN: 21-94-52  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/17/2022
AMPICILLIN 250MG (VIAL)
09/17/2022
09/24/2022
IV
120mg
Q12
Potentially Septic Newborn (Thinly Msaf)
Waiting Final Action 
09/17/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
09/17/2022
09/24/2022
IV
36mg
Q24h
Potentially Septic Newborn (Thinly Msaf)
Waiting Final Action 
08/24/2025
CEFUROXIME 750MG (VIAL)
08/24/2025
08/31/2025
IV
290mg
Q8H
Acute Bacterial Infection
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: